TABLE 1.
Wild type or mutant | E1 region | Infectivitya | Core secretionb | E1E2 heterodimerization and foldingc |
Infection inhibition assaysd |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CD81 PD |
IP AR5A | IP AR4A | hCD81 LEL | Anti-E1E2 |
Anti-CD81 | Anti-CLDN1 | Anti-SRBI | ||||||
E1 | E2 | AR5A | AR4A | ||||||||||
Wild type | +++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | |
G278A | FP | – | – | – | ++ | – | NDe | ND | ND | ND | ND | ND | ND |
D279A | FP | – | – | – | ++ | + | ND | ND | ND | ND | ND | ND | ND |
G282A | FP | – | – | ++ | ++ | ++ | ND | ND | ND | ND | ND | ND | ND |
L286A | FP | ++ | – | + | ++ | ++ | ++ | ++ | ++ | ++ | ++ | +++ | ++ |
Q289A | FP | +++ | ++ | ++ | ++ | ++ | ND | ND | ND | ND | ND | ND | ND |
Q302A | – | – | – | ++ | – | ND | ND | ND | ND | ND | ND | ND | |
E303A | ++ | – | + | ++ | + | + | ++ | ++ | ++ | ++ | +++ | ++ | |
Y309A | – | – | – | ++ | – | ND | ND | ND | ND | ND | ND | ND | |
G311A | + | ++ | ++ | ++ | ++ | ND | ND | ND | ND | ND | ND | ND | |
T314A | + | ++ | ++ | ++ | ++ | ND | ND | ND | ND | ND | ND | ND | |
G315A | α2 | + | ++ | ++ | ++ | ++ | ND | ND | ND | ND | ND | ND | ND |
H316A | α2 | + | ++ | + | ++ | + | ND | ND | ND | ND | ND | ND | ND |
R317A | α2 | +++ | ++ | ++ | ++ | ++ | ND | ND | ND | ND | ND | ND | ND |
M318A | α2 | – | ++ | ++ | ++ | ++ | ND | ND | ND | ND | ND | ND | ND |
W320A | α2 | – | ++ | ++ | ++ | ++ | ND | ND | ND | ND | ND | ND | ND |
D321A | α2 | – | ++ | ++ | ++ | ++ | ND | ND | ND | ND | ND | ND | ND |
M322A | α2 | – | ++ | ++ | ++ | ++ | ND | ND | ND | ND | ND | ND | ND |
M323A | α2 | ++ | ++ | ++ | ++ | ++ | ++ | ++ | +++ | +++ | ++ | +++ | – |
W326A | ++ | ++ | ++ | ++ | ++ | ++ | ++ | +++ | +++ | ++ | ++ | – | |
P328A | +++ | ++ | ++ | ++ | ++ | ++ | ++ | +++ | +++ | ++ | +++ | – | |
R339A | ++ | ++ | ++ | ++ | ++ | ++ | + | +++ | +++ | ++ | ++ | – | |
P341A | – | + | ++ | ++ | ++ | ND | ND | ND | ND | ND | ND | ND |
The infectivity of HCVcc harboring the different E1E2 glycoproteins in the supernatant of electroporated Huh-7 cells was quantified 96 h postelectroporation (Fig. 3). +++, infectious titers higher than 104 FFU/ml; ++, infectious titers higher than 103 FFU/ml; +, infectious titers higher than 102 FFU/ml; −, titers between 0 and 50 FFU/ml.
Secretion of core Ag in the supernatant quantified at 48 h postelectroporation of Huh-7 cells (Fig. 4). ++, concentration greater than or equal to the wild type; +, concentration reduced by <1 log.; −, concentration reduced by ≥1 log.
The recognition of E1E2 proteins by AR4A and AR5A conformational antibodies and their interaction with hCD81 LEL were determined by precipitation experiments (Fig. 5). ++, similar amount of E1E2 precipitated to that of the wild type; +, lower amount of E1E2 precipitated; −, no E1E2 precipitated.
The sensitivity of the mutants to inhibition of infectivity by different antibodies or the hCD81 LEL was assessed (Fig. 6 and 7). ++, wild-type sensitivity to neutralization; +++, higher sensitivity to inhibition than the wild type; +, lower sensitivity to inhibition than the wild type.
ND, not determined.